PharmassetX Inc.

LOUISVILLE, KY · Founded 2024 · Biotech · Private

Galenexib, a novel small molecule therapeutic drug for chronic inflammatory diseases

Claim this profile

Follows are private to you and power your alerts

Updated · pharmassetx.com

Sector
Biotech
Headquarters
LOUISVILLE, KY
Founded
2024
Latest Form D
$100K, May 2026
Total capital
$150K
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$150K
2 Form D · last May 2026
6 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
1 pending

Capital timeline

20252026FEDERAL ↑EQUITY ↓Cumulative $150K1st Form D$50K2nd Form D$100K
20252026FEDERAL ↑EQUITY ↓Cumulative $150K1st Form D$50K2nd Form D$100K

Latest events

  • Private capital raisedForm D · SEC · 2nd filing$100K
  • Private capital raisedForm D · SEC · 1st filing$50K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings
  • David McClureExecutive Officer, DirectorNamed in SEC Form D filings
  • Gerald DrydenExecutive Officer, DirectorNamed in SEC Form D filings
  • Terry MintonExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 1
  • PendingCrystalline Form Of EPIGALLOCATECHIN-3-GALLATEUSPTOApplication 63718303

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .